The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
ABCB1 gene polymorphism affects the susceptibility to [Methotrexate co-treated with Methylprednisolone]; ABCB1 protein results in increased susceptibility to [Methotrexate co-treated with Methylprednisolone]; Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Methylprednisolone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Methylprednisolone] Methylprednisolone results in increased expression of ABCB1 mRNA; Methylprednisolone results in increased expression of ABCB1 protein
Methylprednisolone results in decreased phosphorylation of AKT1 protein naringin inhibits the reaction [Methylprednisolone results in decreased phosphorylation of AKT1 protein]
Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]; Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in increased secretion of ALPL protein]]
Methylprednisolone binds to and results in decreased activity of AR protein; Methylprednisolone binds to and results in increased activity of AR protein
Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of BAX mRNA]; Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BAX mRNA]; Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BAX protein]
Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]; Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein]
Methylprednisolone results in decreased secretion of BGLAP protein 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in decreased expression of BGLAP mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in decreased expression of BGLAP protein]; [Nebivolol co-treated with Alendronate] inhibits the reaction [Methylprednisolone results in decreased secretion of BGLAP protein]; Methylprednisolone inhibits the reaction [2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of BGLAP mRNA]; Methylprednisolone inhibits the reaction [2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of BGLAP protein] Methylprednisolone results in decreased expression of BGLAP mRNA; Methylprednisolone results in decreased expression of BGLAP protein
[Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of CAT protein; Alendronate inhibits the reaction [Methylprednisolone results in decreased activity of CAT protein]; Nebivolol promotes the reaction [Alendronate inhibits the reaction [Methylprednisolone results in decreased activity of CAT protein]] Methylprednisolone results in increased activity of CAT protein
Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA] Methylprednisolone results in increased expression of COL1A1 mRNA
Methylprednisolone results in increased expression of DDIT4 protein Testosterone inhibits the reaction [Methylprednisolone results in increased expression of DDIT4 protein]
Methylprednisolone inhibits the reaction [DMD gene mutant form results in increased expression of RELA protein modified form]; Methylprednisolone inhibits the reaction [DMD gene mutant form results in increased expression of SIRT1 mRNA]
Methylprednisolone results in increased expression of FABP4 mRNA 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in increased expression of FABP4 mRNA]
Methylprednisolone results in increased expression of FBXO32 protein Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein]
Methylprednisolone inhibits the reaction [IL4 protein promotes the reaction [STAT6 protein binds to FCER2 promoter]]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 protein]
Methylprednisolone results in increased expression of FOXO1 protein echinacoside inhibits the reaction [Methylprednisolone results in increased expression of FOXO1 protein]; Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FOXO1 protein]
[Polymyxin B co-treated with Methylprednisolone] inhibits the reaction [Alpha-Amanitin results in increased expression of GPT protein]; Methylprednisolone inhibits the reaction [Alpha-Amanitin results in increased expression of GPT protein]
[Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of GPX1 protein Methylprednisolone results in increased activity of GPX1 protein
[Methylprednisolone co-treated with Metoclopramide] results in decreased activity of HTR3A protein; [Methylprednisolone co-treated with ramosetron] results in decreased activity of HTR3A protein Methylprednisolone results in decreased activity of HTR3A protein
Methylprednisolone inhibits the reaction [IL4 protein promotes the reaction [STAT6 protein binds to FCER2 promoter]]; Methylprednisolone inhibits the reaction [IL4 protein results in increased activity of and results in increased phosphorylation of STAT6 protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of FCER2 protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of IL4R protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of JAK1 protein] Methylprednisolone results in decreased expression of IL4 protein
Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R mRNA]; Methylprednisolone inhibits the reaction [IL4 protein results in increased expression of IL4R protein]; Methylprednisolone inhibits the reaction [IL4 protein results in increased phosphorylation of IL4R protein]
Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA] Methylprednisolone results in decreased expression of IL6 mRNA; Methylprednisolone results in decreased expression of IL6 protein
cobaltiprotoporphyrin inhibits the reaction [Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]
cobaltous chloride inhibits the reaction [Methylprednisolone results in decreased expression of MAPK1 protein modified form]; cobaltous chloride inhibits the reaction [Methylprednisolone results in decreased phosphorylation of MAPK1 protein]
Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of MPO protein] Methylprednisolone results in decreased expression of MPO protein [Polymyxin B co-treated with Methylprednisolone] inhibits the reaction [Alpha-Amanitin results in increased activity of MPO protein]; Methylprednisolone inhibits the reaction [Alpha-Amanitin results in increased activity of MPO protein]
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in increased expression of PPARG mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in increased expression of PPARG protein]; Methylprednisolone inhibits the reaction [2,2-bis(4-glycidyloxyphenyl)propane results in decreased expression of PPARG mRNA]; Methylprednisolone inhibits the reaction [2,2-bis(4-glycidyloxyphenyl)propane results in decreased expression of PPARG protein] Methylprednisolone results in increased expression of PPARG mRNA; Methylprednisolone results in increased expression of PPARG protein
Methylprednisolone results in increased activity of REN protein Sodium Chloride inhibits the reaction [Methylprednisolone results in increased activity of REN protein]
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in decreased expression of RUNX2 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Methylprednisolone results in decreased expression of RUNX2 protein]; Methylprednisolone inhibits the reaction [2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of RUNX2 protein] Methylprednisolone results in decreased expression of RUNX2 mRNA; Methylprednisolone results in decreased expression of RUNX2 protein
[Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of SOD2 protein Methylprednisolone results in increased activity of SOD2 protein Methylprednisolone results in decreased expression of SOD2 mRNA
Methylprednisolone inhibits the reaction [IL4 protein promotes the reaction [STAT6 protein binds to FCER2 promoter]]; Methylprednisolone inhibits the reaction [IL4 protein results in increased activity of and results in increased phosphorylation of STAT6 protein]
Methylprednisolone inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TNF mRNA] Methylprednisolone results in decreased expression of TNF protein [Cyclophosphamide co-treated with Methylprednisolone] inhibits the reaction [Paraquat results in increased expression of TNF protein]
Methylprednisolone results in increased expression of TRIM63 protein Testosterone inhibits the reaction [Methylprednisolone results in increased expression of TRIM63 protein]